Meta-analysis and GWAS analysis indicate that the GCKR rs1260326 has possibly impaired the hepatic lipid metabolism and significantly contributes to the development of obesity and obesity-associated metabolic disorder including NAFLD and T2DM. The gene discussed is GCKR; the disease is metabolic dysfunction-associated steatotic liver disease.